News

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults.

Triple-negative breast cancer patients with obesity-driven diabetes often have worse outcomes. A new study by researchers helps explain why this happens and suggests a potential way to improve treatment.

A new study led by researchers at the University of Cambridge has revealed the mechanism behind how aspirin could reduce metastasis of some cancers by stimulating the immune system.

A new approach to monitoring molecular processes deep in tissues could accelerate personalized medicine, cancer diagnostics and disease detection.

A University of Michigan study found genetic changes in firefighters exposed to wildland-urban interface fires. Researchers observed shifts in microRNAs linked to immune function, inflammation and cancer risk.

Many cancer patients go on to develop heart failure - because of the cancer itself and also due to chemotherapy. But a new study published today shows that a type of diabetes medication called an SGLT2 inhibitor, may help protect the heart.

A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that migrate from the pancreas to the liver.

Researchers developed a microfluidic device that sorts breast cancer cells by adhesion strength. Weakly adherent cells were linked to aggressive tumors, while strongly adherent cells were associated with less invasive cancers.

Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine, which they hope to repurpose as a cancer treatment.

A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined with a synergistic treatment approach.